CLINICAL_TRIALS
trial_result
· 2008-11-11
Clinical Trial Update: Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia [Phase 1, Phase 2]
Summary
Update on a Phase 1/2 ex vivo immunotherapy trial for aplastic anemia, assessing safety and efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shenzhen Zhongxing Yangfan Biotech Co. Ltd. | Conditions: Anemia, Aplastic | Phase 1, Phase 2 | Status: UNKNOWN